Childhood-onset disease as a predictor of mortality in an adult cohort of patients with systemic lupus erythematosus
- PMID: 20235215
- PMCID: PMC3755501
- DOI: 10.1002/acr.20179
Childhood-onset disease as a predictor of mortality in an adult cohort of patients with systemic lupus erythematosus
Abstract
Objective: To examine childhood-onset disease as a predictor of mortality in a cohort of adult patients with systemic lupus erythematosus (SLE).
Methods: Data were derived from the University of California Lupus Outcomes Study, a longitudinal cohort of 957 adult subjects with SLE that includes 98 subjects with childhood-onset SLE. Baseline and followup data were obtained via telephone interviews conducted in 2002-2007. The number of deaths during 5 years of followup was determined and standardized mortality ratios (SMRs) for the cohort, and across age groups, were calculated. Kaplan-Meier life table analysis was used to compare mortality rates between childhood- (defined as SLE diagnosis at <18 years of age) and adult-onset SLE. Multivariate Cox proportional hazard models were used to determine predictors of mortality.
Results: During the median followup period of 48 months, 72 deaths (7.5% of subjects) occurred, including 9 deaths (12.5%) in subjects with childhood-onset SLE. The overall SMR was 2.5 (95% confidence interval [95% CI] 2.0-3.2). In Kaplan-Meier survival analysis, after adjusting for age, childhood-onset subjects were at increased risk for mortality throughout the followup period (P< 0.0001). In a multivariate model adjusting for age, disease duration, and other covariates, childhood-onset SLE was independently associated with an increased mortality risk (hazard ratio [HR] 3.1, 95% CI 1.3-7.3), as was low socioeconomic status measured by education (HR 1.9, 95% CI 1.1-3.2), and end stage renal disease (HR 2.1, 95% CI 1.1-4.0).
Conclusion: Childhood-onset SLE was a strong predictor of mortality in this cohort. Interventions are needed to prevent early mortality in this population.
Figures
Similar articles
-
Assessing the relative impact of lupus nephritis on mortality in a population-based systemic lupus erythematosus cohort.Lupus. 2019 Jun;28(7):818-825. doi: 10.1177/0961203319847275. Epub 2019 May 9. Lupus. 2019. PMID: 31072277
-
Association between serum total cholesterol level and renal outcome in systemic lupus erythematosus.Arthritis Rheum. 2006 Jul;54(7):2211-9. doi: 10.1002/art.21929. Arthritis Rheum. 2006. PMID: 16802357
-
Increased risk of death in pediatric and adult patients with ESRD secondary to lupus.Pediatr Nephrol. 2011 Jan;26(1):93-8. doi: 10.1007/s00467-010-1640-9. Epub 2010 Oct 3. Pediatr Nephrol. 2011. PMID: 20890767 Free PMC article.
-
Differences in Clinical Features and Mortality between Childhood-onset and Adult-onset Systemic Lupus Erythematosus: A Prospective Single-center Study.J Rheumatol. 2016 Aug;43(8):1490-7. doi: 10.3899/jrheum.151129. Epub 2016 Jun 1. J Rheumatol. 2016. PMID: 27252431
-
Onset age affects mortality and renal outcome of female systemic lupus erythematosus patients: a nationwide population-based study in Taiwan.Rheumatology (Oxford). 2014 Jan;53(1):180-5. doi: 10.1093/rheumatology/ket330. Epub 2013 Oct 17. Rheumatology (Oxford). 2014. PMID: 24136069
Cited by
-
Improving lupus care index documentation in patients with childhood-onset systemic lupus erythematosus.Front Pediatr. 2024 Aug 27;12:1428644. doi: 10.3389/fped.2024.1428644. eCollection 2024. Front Pediatr. 2024. PMID: 39258146 Free PMC article.
-
Systemic lupus erythematosus patients have unique changes in serum metabolic profiles across age associated with cardiometabolic risk.Rheumatology (Oxford). 2024 Oct 1;63(10):2741-2753. doi: 10.1093/rheumatology/kead646. Rheumatology (Oxford). 2024. PMID: 38048621 Free PMC article.
-
Atherosclerosis Progression in the APPLE Trial Can Be Predicted in Young People With Juvenile-Onset Systemic Lupus Erythematosus Using a Novel Lipid Metabolomic Signature.Arthritis Rheumatol. 2024 Mar;76(3):455-468. doi: 10.1002/art.42722. Epub 2023 Dec 19. Arthritis Rheumatol. 2024. PMID: 37786302 Clinical Trial.
-
In-hospital mortality and associated factors in patients with systemic lupus erythematosus: analysis over more than 11 years in a reference hospital center.Rheumatol Int. 2023 Dec;43(12):2221-2231. doi: 10.1007/s00296-023-05469-1. Epub 2023 Sep 30. Rheumatol Int. 2023. PMID: 37776497
-
Persisting mortality gap in systemic lupus erythematosus; a population-based study on juvenile- and adult-onset SLE in Norway 1999-2022.Rheumatology (Oxford). 2024 Aug 1;63(8):2109-2117. doi: 10.1093/rheumatology/kead519. Rheumatology (Oxford). 2024. PMID: 37769251 Free PMC article.
References
-
- Borchers AT, et al. Surviving the butterfly and the wolf: mortality trends in systemic lupus erythematosus. Autoimmun Rev. 2004;3(6):423–53. - PubMed
-
- Ippolito A, Petri M. An update on mortality in systemic lupus erythematosus. Clin Exp Rheumatol. 2008;26(5 Suppl 51):S72–9. - PubMed
-
- Trager J, Ward MM. Mortality and causes of death in systemic lupus erythematosus. Curr Opin Rheumatol. 2001;13(5):345–51. - PubMed
-
- Uramoto KM, et al. Trends in the incidence and mortality of systemic lupus erythematosus, 1950-1992. Arthritis Rheum. 1999;42(1):46–50. - PubMed
-
- Kasitanon N, Magder LS, Petri M. Predictors of survival in systemic lupus erythematosus. Medicine (Baltimore) 2006;85(3):147–56. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
